Aspira Women's Health Inc.

AWHL | OTC | CIK: 0000926617 | SIC: 2835 In Vitro & In Vivo Diagnostic Substances | active
Aspira Women's Health Inc. is a commercial-stage diagnostics company focused on gynecological disease detection in women. The company develops and markets diagnostic tests including Ova1, Overa, Ova1Plus, OvaWatch, ENDOinform, and OVAinform for ovarian cancer risk assessment, endometriosis, and benign pelvic mass monitoring. Operating through its laboratory subsidiary Aspira Labs, the company also offers the Aspira Synergy platform and Aspira Genetix genetic testing services.
ovarian-cancer-diagnosticsendometriosis-diagnosticsgynecological-disease-diagnosticswomen's-healthclinical-laboratory-serviceslaboratory-developed-tests-(ldts)fda-clearance/approval-standards-for-medical-devices

Products

NameTypeDescription
Ova1serviceDiagnostic test for ovarian cancer risk assessment in women with pelvic mass
OveraserviceDiagnostic test for ovarian cancer risk assessment
Ova1PlusserviceCombined ovarian cancer risk assessment test offering
OvaWatchserviceBenign pelvic mass monitoring diagnostic test
ENDOinformserviceDiagnostic informatics product for endometriosis
OVAinformserviceOvarian cancer risk assessment informatics product
Aspira SynergyplatformDecentralized platform for risk assessment tests and partnerships
Aspira GenetixserviceGenetic testing service offered through Aspira Labs
OvaCalcsoftwareCalculation tool related to ovarian cancer risk assessment
OvaSuiteplatformSuite of ovarian health diagnostic tools

Partnerships

PartnerTypeDescription
Quest Diagnostics IncorporatedstrategicContinuing future services provided to Aspira
BioReference Health, LLCstrategicContinuing future services provided to Aspira
NovitasstrategicMedicare Administrative Carrier providing local and/or national coverage for Ova1

SEC Filings

View all SEC EDGAR filings: EDGAR Company Page

Structured filing index: /api/company/AWHL/filings

Origin — Data Provenance
This profile was extracted from SEC EDGAR filings (PEM-signed by sec.gov).
Every API response includes a cryptographic origin leaf for chain-of-custody tracking.
AI Discovery Document | Registry Metrics | GitHub